Consolidated Statements of Operations (Unaudited) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Operating costs and expenses
Research and development	$ 2,025,120	$ 785,274
Research and development - licenses acquired	95,000	230,693
Compensation and related expenses (including stock-based compensation)	2,932,933	509,667
Professional fees (including stock-based compensation)	2,091,745	682,929
Rent	31,622	28,252
Other expenses	538,577	258,710
Total operating expenses	7,714,997	2,495,525
Loss from operations	(7,714,997)	(2,495,525)
Other income (expenses)
Other income, net	10,636
Loss on foreign currency exchange	(275)
Total other income	10,361
Net loss	$ (7,704,636)	$ (2,495,525)
Weighted average number of common shares outstanding, basic and diluted	9,164,577	5,031,062
Net loss per share, basic and diluted	$ (0.84)	$ (0.50)